• Explore /
  • Poster
  • / Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).

Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).

Abstract Video & Slides Poster

Authors

null

Marwan Fakih

City of Hope Comprehensive Cancer Center, Duarte, CA

Marwan Fakih , Kanwal Pratap Singh Raghav , David Z. Chang , Johanna C. Bendell , Timothy Larson , Allen Lee Cohn , Timothy K. Huyck , David Cosgrove , Joseph A. Fiorillo , Lawrence E. Garbo , Shruthi Ravimohan , Von Potter , David D'Adamo , Neelesh Sharma , Ying A. Wang , Sabine Coppieters , Matthias Herpers , Carolina Soares Viana de Oliveira , Andrew Scott Paulson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Clinical Trial Registration Number

NCT04126733

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3560)

DOI

10.1200/JCO.2021.39.15_suppl.3560

Abstract #

3560

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Rui Liu

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Gastric cancer (GC) cohort of a phase 2 trial of E7389-LF (liposomal formulation of eribulin) in combination with nivolumab.

Gastric cancer (GC) cohort of a phase 2 trial of E7389-LF (liposomal formulation of eribulin) in combination with nivolumab.

First Author: Kei Muro

First Author: Miao Wang

First Author: Manish R. Patel